[email protected] & No phone number available.

Craig Audet

Dr. Craig Michael Audet is the founder of WRS Regulatory Consultants, a consulting firm specializing in pharmaceutical regulatory... | South Yarmouth, Massachusetts, United States

*50 free lookup(s) per month.

No credit card required.

Craig Audet’s Emails [email protected]

Craig Audet’s Phone Numbers No phone number available.

Social Media

Craig Audet’s Location South Yarmouth, Massachusetts, United States

Craig Audet’s Expertise Dr. Craig Michael Audet is the founder of WRS Regulatory Consultants, a consulting firm specializing in pharmaceutical regulatory strategy and submission development. Dr. Audet is a senior executive with 37+ years of experience in the global pharmaceutical and biotechnology industry, spanning multiple therapeutic areas. His experience covers the regulatory aspects of discovery research, clinical R&D, health authority submissions and approvals, commercialization, and marketing. He has been involved in the development and commercialization of numerous drugs, including Lipitor (cholesterol lowering), Exubra (inhaled insulin), Caduet (cholesterol and blood pressure lowering), Ambien (insomnia), Plavix (acute coronary syndrome), Belviq (weight loss), and Adstiladrin (bladder cancer). Dr. Audet has held strategic leadership positions as Sr. Director, Global Therapeutic Area Leader at Pfizer, VP US Regulatory Affairs at Sanofi, and SVP Global Regulatory Affairs at Arena Pharmaceuticals. Dr. Audet holds a BS in biology/pre-medicine from Boston College and a PhD in public health with a specialization in community health from Walden University and served as an adjunct Associate Professor at Temple University’s School of Pharmacy.

Craig Audet’s Current Industry Halloran Consulting

Not the Craig Audet you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Halloran Consulting

Principal Consultant

Sun Sep 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Aug 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Wrs Regulatory Consultants

Independent Consultant

Thu Aug 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Present

Evofem Biosciences

Sr. Vice President, Regulatory Affairs & Quality Assurance

Wed Mar 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Oct 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Arena Pharmaceuticals

Sr. Vice President, Operations & Head of Global Regulatory Affairs/Executive Officer

Fri Apr 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Oct 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Worldwide Regulatory Services

President

Sun Aug 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)

Sanofi Aventis

VP, US Regulatory Affairs

Mon Dec 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Aug 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)

Temple University

Adjunct Associate Professor

Thu Aug 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Jul 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)

Pfizer Pharmaceuticals

Global Therapeutic Area Leader - CV Products

Sun Mar 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Dec 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)

United States Surgical

Director, Corporate Regulatory Affairs

Wed Jan 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Mar 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time)

Stratoinfusaid

Director, Worldwide Regulatory Affairs

Wed Dec 01 1993 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jan 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time)

Bard Vascular Systems Division

Manager, Regulatory Affairs

Sat Sep 01 1990 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Dec 01 1993 00:00:00 GMT+0000 (Coordinated Universal Time)

Lubrx Products

Regulatory Affairs Supervisor

Thu May 01 1986 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Sep 01 1990 00:00:00 GMT+0000 (Coordinated Universal Time)

Skills

Languages

Craig Audet Email Addresses

[email protected] Email

Craig Audet Phone Number

No phone number available. Phone number

FAQ About Craig Audet

Craig Audet is located at
South Yarmouth, Massachusetts, United States

Craig Audet is a
Dr. Craig Michael Audet is the founder of WRS Regulatory Consultants, a consulting firm specializing in pharmaceutical regulatory strategy and submission development. Dr. Audet is a senior executive with 37+ years of experience in the global pharmaceutical and biotechnology industry, spanning multiple therapeutic areas. His experience covers the regulatory aspects of discovery research, clinical R&D, health authority submissions and approvals, commercialization, and marketing. He has been involved in the development and commercialization of numerous drugs, including Lipitor (cholesterol lowering), Exubra (inhaled insulin), Caduet (cholesterol and blood pressure lowering), Ambien (insomnia), Plavix (acute coronary syndrome), Belviq (weight loss), and Adstiladrin (bladder cancer). Dr. Audet has held strategic leadership positions as Sr. Director, Global Therapeutic Area Leader at Pfizer, VP US Regulatory Affairs at Sanofi, and SVP Global Regulatory Affairs at Arena Pharmaceuticals. Dr. Audet holds a BS in biology/pre-medicine from Boston College and a PhD in public health with a specialization in community health from Walden University and served as an adjunct Associate Professor at Temple University’s School of Pharmacy. Halloran Consulting

Craig Audet currently works in the
Halloran Consulting

Craig Audet specializes in
Dr. Craig Michael Audet is the founder of WRS Regulatory Consultants, a consulting firm specializing in pharmaceutical regulatory strategy and submission development. Dr. Audet is a senior executive with 37+ years of experience in the global pharmaceutical and biotechnology industry, spanning multiple therapeutic areas. His experience covers the regulatory aspects of discovery research, clinical R&D, health authority submissions and approvals, commercialization, and marketing. He has been involved in the development and commercialization of numerous drugs, including Lipitor (cholesterol lowering), Exubra (inhaled insulin), Caduet (cholesterol and blood pressure lowering), Ambien (insomnia), Plavix (acute coronary syndrome), Belviq (weight loss), and Adstiladrin (bladder cancer). Dr. Audet has held strategic leadership positions as Sr. Director, Global Therapeutic Area Leader at Pfizer, VP US Regulatory Affairs at Sanofi, and SVP Global Regulatory Affairs at Arena Pharmaceuticals. Dr. Audet holds a BS in biology/pre-medicine from Boston College and a PhD in public health with a specialization in community health from Walden University and served as an adjunct Associate Professor at Temple University’s School of Pharmacy.

Craig Audet speaks the following languages:
No languages available.

Craig Audet has prior experience in the following industries:
Halloran Consulting , Evofem Biosciences , Arena Pharmaceuticals , Worldwide Regulatory Services , Sanofi Aventis , Temple University , Pfizer Pharmaceuticals , United States Surgical , Stratoinfusaid , Bard Vascular Systems Division , Lubrx Products

Craig Audet has the following professional experience:
Halloran Consulting , Wrs Regulatory Consultants , Evofem Biosciences , Arena Pharmaceuticals , Worldwide Regulatory Services , Sanofi Aventis , Temple University , Pfizer Pharmaceuticals , United States Surgical , Stratoinfusaid , Bard Vascular Systems Division , Lubrx Products .